ResMed | RMD - Current Assets


ResMed reported $4.32B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Ansell USD 1.11B 5.2M Dec/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 345.53M 31.84M Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Cochlear AUD 1.37B 43.9M Dec/2025
Cooper Companies USD 2.28B 18.3M Jun/2026
CSL USD 11.85B 1000K Dec/2025
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Fisher Paykel Healthcare NZD 1.15B 168.5M Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Haemonetics USD 810.83M 24.05M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
Medtronic USD 24.39B 397M Jun/2026
Philips EUR 9.33B 454M Jun/2026
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 4.32B 260.68M Jun/2026
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Steris USD 2.45B 51.2M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026